Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Bristol-Myers Squibb
(NY:
BMY
)
58.88
-1.71 (-2.82%)
Streaming Delayed Price
Updated: 12:08 PM EDT, May 1, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Bristol-Myers Squibb
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
89
90
Next >
Sanofi, Eli Lilly, Novo Nordisk, AstraZeneca Face Renewed Claims Of Conspiring To Restrict 340B Discounts
↗
August 11, 2025
A federal appeals court revived a lawsuit accusing Sanofi, Eli Lilly, Novo Nordisk, and AstraZeneca of conspiring to restrict 340B drug discounts for safety-net clinics, sending the case back to...
Via
Benzinga
Topics
Lawsuit
PRME Revenue Misses by 73%
↗
August 07, 2025
Via
The Motley Fool
Is It Time to Buy Biotech Stocks?
↗
August 06, 2025
A surge in private market investment has investors wondering: Is it time to bet bigger on biotech?
Via
The Motley Fool
RFK Jr. Sued By Eli Lilly, Amgen Over Drug Discount Program
↗
August 06, 2025
Eli Lilly and Amgen are suing HHS over 340B certifications, claiming ineligible clinics cost them millions in lost revenue.
Via
Benzinga
Topics
Lawsuit
Meta, Microsoft Power Wall Street To New Records Despite Inflation Jump: What's Moving Markets Thursday?
↗
July 31, 2025
A post-earnings surge in Meta Platforms Inc. (NASDAQ:META) and Microsoft Corp.
Via
Benzinga
Topics
Economy
Earnings Scheduled For July 31, 2025
↗
July 31, 2025
Via
Benzinga
Bristol-Myers Squibb Earnings Preview
↗
July 30, 2025
Via
Benzinga
1 Small-Cap Biotech Stock Poised for a Breakout
↗
August 06, 2025
This developmental biotech is nearing a key inflection point.
Via
The Motley Fool
Topics
Economy
Bristol Myers Squibb’s Application for Breyanzi (lisocabtagene maraleucel) Accepted for Priority Review by U.S. Food and Drug Administration (FDA) in Fifth Cancer Type for Relapsed or Refractory Marginal Zone Lymphoma (MZL)
August 04, 2025
From
Bristol Myers Squibb
Via
Business Wire
Why Is Replimune Stock Trading Lower On Monday?
↗
August 04, 2025
Replimune stock falls as FDA denies skin cancer drug approval and investors sue over alleged misstatements tied to the IGNYTE trial.
Via
Benzinga
BioNTech Narrows Losses, Q2 Revenue Doubles As Vaccine Collaboration Drives Growth
↗
August 04, 2025
BioNTech beat Q2 estimates with higher COVID vaccine revenue and reaffirmed 2025 guidance.
Via
Benzinga
Late-Stage Pipeline Wins Boost Investor Confidence in High-Growth Therapeutic Areas
August 04, 2025
Via
Investor Brand Network
Topics
Government
Late-Stage Pipeline Wins Boost Investor Confidence in High-Growth Therapeutic Areas
August 04, 2025
EQNX::TICKER_START (NASDAQ:SNGX),(NYSE:PFE),(NYSE:MRK),(NYSE:BMY),(NASDAQ:INSM) EQNX::TICKER_END
Via
FinancialNewsMedia
Topics
Government
This Biotech Stock Could Soar on Upcoming Clinical Data
↗
August 04, 2025
This weight loss drugmaker may be significantly undervalued right now.
Via
The Motley Fool
Bristol Myers (BMY) Q2 EPS Jumps 36%
↗
August 01, 2025
Via
The Motley Fool
Topics
Intellectual Property
Trump Issues 60 Day Ultimatum To US Pharma Giants To Slash Drug Prices: 'If You Refuse To Step Up We Will...'
↗
August 01, 2025
President Donald Trump has issued a 60-day ultimatum to 17 major pharmaceutical companies, demanding that they lower drug prices in the U.S. or face severe consequences.
Via
Benzinga
Topics
Government
Trump Turns Up Heat On Big Pharma CEOs To Slash Drug Prices Within 60 Days — But Retail Traders Don't Flinch
↗
July 31, 2025
Via
Stocktwits
Topics
Government
Bristol-Myers Squibb Unusual Options Activity For July 31
↗
July 31, 2025
Via
Benzinga
Why Bristol-Myers Squibb (BMY) Stock Is Trading Lower Today
July 31, 2025
Shares of biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) fell 4.2% in the afternoon session after the company lowered its full-year earnings forecast, overshadowing second-quarter results...
Via
StockStory
Topics
Intellectual Property
World Trade
Bristol-Myers Squibb (NYSE:BMY) Reports Strong Q2, Full-Year Sales Guidance is Optimistic
July 31, 2025
Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) announced better-than-expected revenue in Q2 CY2025, but sales were flat year on year at $12.27 billion. The company’s full-year revenue...
Via
StockStory
Bristol Myers Cuts Earnings Outlook As Legacy Drugs Face Generic Erosion
↗
July 31, 2025
Bristol Myers beat Q2 sales expectations but cut its 2025 EPS forecast as strategic charges and legacy product declines weighed on earnings.
Via
Benzinga
Bristol-Myers Squibb Co (NYSE:BMY) Surpasses Q2 2025 Earnings and Revenue Estimates, Shares Rise in Pre-Market Trading
↗
July 31, 2025
Bristol-Myers Squibb (BMY) beats Q2 2025 revenue and EPS estimates, driving a 2.9% pre-market stock surge. Strong oncology, immunology, and cardiovascular drug sales fuel growth.
Via
Chartmill
BRISTOL-MYERS SQUIBB CO (NYSE:BMY) – A High-Yield Dividend Stock with Strong Profitability and Financial Health
↗
July 31, 2025
Bristol-Myers Squibb (BMY) offers a high 5.06% dividend yield, strong profitability, and solid financial health, making it a top pick for income investors. Its undervalued stock and consistent payout...
Via
Chartmill
Bristol Myers Squibb Reports Second Quarter Financial Results for 2025
July 31, 2025
From
Bristol Myers Squibb
Via
Business Wire
Stock Market Today: S&P 500, Nasdaq To Open Higher After Robust Meta, Microsoft Earnings—Investors Await Apple, Amazon Results
↗
July 31, 2025
U.S. stock futures rose on Thursday after ending on a mixed note on Wednesday. Futures of major benchmark indices were higher, except for the small-cap gauge Russell 2000.
Via
Benzinga
Topics
Stocks
Dow Falls Over 150 Points After Powell's Comments On Rate Cuts: Investor Sentiment Declines, But Fear Index Remains In 'Greed' Zone
↗
July 31, 2025
US stocks fell on Wednesday, with the Dow dropping over 150 points after Fed Chair Powell's comments. Fear Index remained in Greed zone.
Via
Benzinga
Topics
Economy
Stocks
Microsoft, Apple And 3 Stocks To Watch Heading Into Thursday
↗
July 31, 2025
U.S. stock futures up, Apple, Amazon, Meta report strong earnings, Microsoft beats forecast, Bristol-Myers Squibb to release results.
Via
Benzinga
Bristol Myers Squibb: A Stock with Potential Amid Challenges
↗
July 30, 2025
Via
The Motley Fool
Got $500? 3 Blue Chip Dividend Stocks to Buy and Hold Forever
↗
July 30, 2025
Being a great investor doesn't have to be complicated or expensive.
Via
The Motley Fool
Topics
Intellectual Property
3 Low-Volatility Stocks We Find Risky
July 30, 2025
Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.
Via
StockStory
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
89
90
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
